查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1525927

嬰兒臨床營養市場：全球產業分析、規模、份額、成長、趨勢、預測，2024-2033 年

Infant Clinical Nutrition Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 159 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research最近發佈了一份關於全球嬰兒臨床營養市場的綜合報告。該報告全面評估了主要市場動態，包括市場驅動因素、趨勢、機會和課題，並提供了有關市場結構的詳細見解。

重要見解

  • 嬰兒臨床營養市場規模（2024年）：274.918億美元
  • 市場預測值（2033F）：457.337億美元
  • 全球市場成長率（2024年至2033年複合年增長率）：5.8%

嬰兒臨床營養市場 - 報告範圍：

嬰兒臨床營養在全球支持新生兒和嬰兒的健康和發育方面發揮著重要作用。該市場包括專為嬰兒設計的各種營養產品，例如嬰兒配方奶粉、嬰兒食品和營養補充劑。該市場的主要利益相關者包括製造商、醫療保健提供者和監管機構，每個人都為市場成長和監管框架做出了貢獻。

市場成長動力：

全球嬰兒臨床營養市場由幾個關鍵因素推動，包括出生率的提高、對幼兒營養重要性的認識不斷提高以及營養科學的進步。市場擴張是由對專門嬰兒配方奶粉的需求推動的，這些配方奶粉可以解決各種健康問題，包括乳糖不耐症、過敏和早產併發症。此外，注重健康的父母越來越多地採用有機和天然嬰兒食品，這進一步推動了市場的成長。

市場限制因素：

儘管成長前景廣闊，但嬰兒臨床營養市場面臨嚴格監管要求的課題，特別是在產品安全、標籤和聲明方面。此外，經濟波動、定價壓力和供應鏈中斷正在影響市場動態，並對旨在實現永續獲利和市場擴張的市場參與者構成課題。

市場機會：

由於人口趨勢、不斷變化的飲食偏好以及營養研究的進步，嬰兒臨床營養市場呈現出巨大的成長機會。產品配方的創新，例如低過敏性嬰兒配方奶粉和富含益生菌的嬰兒食品，正在滿足消費者對更健康、更功能性嬰兒營養選擇的新需求。製造商、醫療保健提供者和營養學家之間的策略合作對於開發基於證據的營養解決方案和向不同人群拓展市場至關重要。

本報告解決的關鍵問題

  • 推動全球嬰兒臨床營養市場成長的關鍵因素是什麼？
  • 哪些產品領域和營養配方越來越受到家長和醫療保健提供者的採用？
  • 監管環境與消費者偏好如何形塑嬰兒臨床營養市場的競爭格局？
  • 誰是對嬰兒臨床營養市場做出貢獻的主要公司？ 他們保持市場領先地位的策略是什麼？
  • 全球嬰幼兒臨床營養市場有何新趨勢與未來前景？

目錄

第1章 內容提要

第2章 市場概況

  • 市場範圍/分類
  • 市場定義/範圍/限制

第3章 主要市場趨勢

  • 影響市場的主要趨勢
    • 出生率上升和早產增加增加了對嬰兒營養補充劑的需求
    • 嬰兒食品營養改善的進步推動市場成長
  • 產品創新/發展趨勢

第4章 關鍵成功因素

  • 產品採用/使用分析
  • 產品 USP/特點
  • 戰略推廣策略

第五章全球嬰兒臨床營養市場-價格分析

  • 2019-2023年區域價格趨勢分析
  • 全球平均價格分析基準

第六章全球嬰幼兒臨床營養市場需求（價值百萬美元）分析

  • 2019-2023 年歷史市值（百萬美元）分析
  • 2024-2033 年當前和未來市場價值（百萬美元）預測
    • 同比增長趨勢分析
    • 絕對的獲利機會

第7章 市場背景

  • 宏觀經濟因素
  • 預測變量 - 相關性和影響
  • 全球食品飲料行業概覽
  • 全球乳製品產業概況
  • 供應鍊和價值鏈分析
  • 政策制定和監管情勢
  • 市場動態
  • 全球供需分析

第八章全球嬰兒臨床營養市場分析：產品類型

  • 簡介/主要發現
  • 2019-2023 年歷史市場規模（百萬美元）（按產品類型）
  • 2024-2033 年當前和未來市場規模（百萬美元）以及按產品類型分析和預測
    • 乳基
    • 以大豆為基礎
    • 有機的
    • 益生菌/益生元
  • 按產品類型分析市場吸引力

第九章全球嬰兒臨床營養市場分析：依給藥途徑

  • 簡介/主要發現
  • 2019-2023 年市場規模（百萬美元）和數量分析（按管理方式）
  • 目前和未來的市場規模（百萬美元）以及定量分析和預測（按管理方式，2024-2033 年）
    • 口服給藥
    • 腸內給藥
    • 靜脈給藥
  • 依給藥途徑進行市場吸引力分析

第十章全球嬰兒臨床營養市場分析：按地區

  • 介紹
  • 2019-2023 年按地區劃分的市場規模（百萬美元）和銷售分析
  • 2024-2033 年按地區劃分的當前市場規模（百萬美元）和銷售分析與預測
    • 北美
    • 拉丁美洲
    • 歐洲
    • 南亞和太平洋地區
    • 東亞
    • 中東和非洲
  • 按地區劃分的市場吸引力分析

第十一章北美嬰兒臨床營養市場分析

第十二章拉丁美洲嬰兒臨床營養市場分析

第十三章歐洲嬰兒臨床營養市場分析

第14章南亞及太平洋地區嬰兒臨床營養市場分析

第十五章東亞嬰幼兒臨床營養市場分析

第十六章中東與非洲嬰幼兒臨床營養市場分析

第十七章 2024 年各國嬰兒臨床營養市場分析

  • 介紹
  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷
  • 德國
  • 義大利
  • 法國
  • 英國
  • 西班牙
  • 波蘭
  • 俄羅斯
  • 中國
  • 日本
  • 韓國
  • 印度
  • 大洋洲（澳洲、紐西蘭）
  • 土耳其
  • 南非

第18章 市場結構分析

  • 按公司類別劃分的市場分析（嬰兒臨床營養）
  • 主要參與者的市場份額分析
  • 市場存在分析

第19章 競爭分析

  • 比賽儀表板
  • 競爭標桿
  • 衝突詳情
    • Abbott Laboratories
    • Baxter International
    • Nestle SA
    • Danone
    • Meiji Holdings Co., Ltd.
    • Fresenius SE & Co. KGaA
    • Reckitt Benckiser Group Plc
    • Perrigo Co. Plc
    • Ingredion Inc.
    • Solace Nutrition
    • 其他（根據額外要求）

第20章 所使用的假設與縮寫詞

第21章 研究方法論

簡介目錄
Product Code: PMRREP22363

Persistence Market Research has recently released a comprehensive report on the worldwide market for infant clinical nutrition. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Infant Clinical Nutrition Market Size (2024E): USD 27491.8 Mn
  • Projected Market Value (2033F): USD 45733.7 Mn
  • Global Market Growth Rate (CAGR 2024 to 2033): 5.8%

Infant Clinical Nutrition Market - Report Scope:

Infant clinical nutrition plays a critical role in supporting the health and development of newborns and infants globally. This market encompasses a wide range of nutritional products designed specifically for infants, including infant formula, baby food, and nutritional supplements. Key stakeholders in this market include manufacturers, healthcare providers, and regulatory bodies, each contributing to the market's growth and regulatory framework.

Market Growth Drivers:

The global infant clinical nutrition market is driven by several key factors, including increasing birth rates, rising awareness about the importance of early childhood nutrition, and advancements in nutritional science. The demand for specialized infant formulas catering to various health conditions such as lactose intolerance, allergies, and preterm birth complications fuels market expansion. Moreover, the growing adoption of organic and natural infant food products among health-conscious parents further stimulates market growth.

Market Restraints:

Despite promising growth prospects, the infant clinical nutrition market faces challenges related to stringent regulatory requirements, particularly concerning product safety, labeling, and advertising claims. Additionally, economic fluctuations, pricing pressures, and supply chain disruptions impact market dynamics, posing challenges for market players aiming for sustained profitability and market expansion.

Market Opportunities:

The infant clinical nutrition market presents significant growth opportunities driven by demographic trends, evolving dietary preferences, and advancements in nutritional research. Innovations in product formulations, such as hypoallergenic formulas and probiotic-enriched baby foods, cater to emerging consumer demands for healthier and functional infant nutrition options. Strategic collaborations between manufacturers, healthcare providers, and nutritionists are crucial in developing evidence-based nutritional solutions and expanding market reach across diverse demographic segments.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the infant clinical nutrition market globally?
  • Which product segments and nutritional formulations are witnessing increased adoption among parents and healthcare providers?
  • How are regulatory developments and consumer preferences shaping the competitive landscape of the infant clinical nutrition market?
  • Who are the key players contributing to the infant clinical nutrition market, and what strategies are they employing to maintain market leadership?
  • What are the emerging trends and future prospects in the global infant clinical nutrition market?

Competitive Intelligence and Business Strategy:

Leading players in the global infant clinical nutrition market, including Nestle S.A., Abbott Laboratories, Danone S.A., Mead Johnson Nutrition Company, and Reckitt Benckiser Group plc, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in research and development to introduce new nutritional products tailored to specific health needs and consumer preferences. Collaborations with pediatricians, hospitals, and retail channels enhance product distribution and market penetration, ensuring comprehensive infant nutrition solutions globally.

Key Companies Profiled:

  • Abbott Laboratories
  • Baxter International Inc.
  • Nestle S.A.
  • Danone
  • Meiji Holdings Co., Ltd.,
  • Fresenius SE & Co. KGaA
  • Reckitt Benckiser Group Plc
  • Perrigo Co. Plc
  • Ingredion Inc.
  • Solace Nutrition

Infant Clinical Nutrition Industry Research by Category

By Product Type:

  • Milk-Based
  • Soy-Based
  • Organic
  • Probiotic/Prebiotic

By Route of Administration:

  • Oral administration
  • Enteral administration
  • Intravenous administration

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia & Pacific
  • East Asia
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Technology Roadmap
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
    • 3.1.1. Increasing Birth Rate with the Growing Number of Premature Births Creates Needs for Infant Nutrition Supplements
    • 3.1.2. Advancements in the Nutritional Modifications in the Infant Food Products to Boost the Market Growth
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Product Adoption / Usage Analysis
  • 4.2. Product USPs / Features
  • 4.3. Strategic Promotional Strategies

5. Global Infant Clinical Nutrition Market - Pricing Analysis

  • 5.1. Regional Pricing Trend Analysis, 2019-2023
  • 5.2. Global Average Pricing Analysis Benchmark

6. Global Infant Clinical Nutrition Market Demand (in Value US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033

  • 6.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 6.2. Current and Future Market Value (US$ Mn) Projections, 2024-2033
    • 6.2.1. Y-o-Y Growth Trend Analysis
    • 6.2.2. Absolute $ Opportunity Analysis

7. Market Background

  • 7.1. Macro-Economic Factors
    • 7.1.1. Global GDP Growth Outlook
    • 7.1.2. Global Food & Beverage industry Overview
    • 7.1.3. Global GDP and Infrastructure Investment
    • 7.1.4. International Trade
    • 7.1.5. Global Industry Outlook
  • 7.2. Forecast Factors - Relevance & Impact
    • 7.2.1. Top Companies Historical Growth
    • 7.2.2. GDP Growth forecast
    • 7.2.3. Manufacturing Industry forecast
    • 7.2.4. Global Urbanization Growth Outlook
    • 7.2.5. Business Climate
  • 7.3. Global Food and Beverage Industry Overview
  • 7.4. Global Dairy Industry Overview
  • 7.5. Supply Chain & Value-Chain Analysis
    • 7.5.1. Raw Material Suppliers
    • 7.5.2. Product Manufacturers
    • 7.5.3. Distribution Channel Industries
  • 7.6. Policy Developments and Regulatory Scenario
    • 7.6.1. The United States Food and Drug Administration (FDA)
    • 7.6.2. Canadian Food Inspection Agency
    • 7.6.3. European Food Safety Authority (EFSA)
    • 7.6.4. The Food Safety and Standards Authority of India (FSSAI)
    • 7.6.5. Ministry of Health, Labor and Welfare. (MHLW), Japan
    • 7.6.6. National Health Commission (NHC), China
    • 7.6.7. Food Standards Australia New Zealand (FSANZ)
  • 7.7. Market Dynamics
    • 7.7.1. Drivers
    • 7.7.2. Restraints
    • 7.7.3. Opportunity Analysis
  • 7.8. Global Supply Demand Analysis

8. Global Infant Clinical Nutrition Market Analysis 2019-2023 and Forecast 2024-2033, by Product Type

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) By Product Type, 2019-2023
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2024-2033
    • 8.3.1. Milk-Based
    • 8.3.2. Soy-Based
    • 8.3.3. Organic
    • 8.3.4. Probiotic/Prebiotic
  • 8.4. Market Attractiveness Analysis By Product Type

9. Global Infant Clinical Nutrition Market Analysis 2019-2023 and Forecast 2024-2033, By Route of Administration

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) and Volume Analysis By Route of Administration, 2019-2023
  • 9.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Route of Administration, 2024-2033
    • 9.3.1. Oral administration
    • 9.3.2. Enteral administration
    • 9.3.3. Intravenous administration
  • 9.4. Market Attractiveness Analysis By Route of Administration

10. Global Infant Clinical Nutrition Market Analysis 2019-2023 and Forecast 2024-2033, by Region

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Mn) and Volume Analysis By Region, 2019-2023
  • 10.3. Current Market Size (US$ Mn) and Volume Analysis and Forecast By Region, 2024-2033
    • 10.3.1. North America
    • 10.3.2. Latin America
    • 10.3.3. Europe
    • 10.3.4. South Asia and Pacific
    • 10.3.5. East Asia
    • 10.3.6. Middle East and Africa (MEA)
  • 10.4. Market Attractiveness Analysis By Region

11. North America Infant Clinical Nutrition Market Analysis 2019-2023 and Forecast 2024-2033

  • 11.1. Introduction
  • 11.2. Pricing Analysis
  • 11.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 11.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
    • 11.4.1. By Country
      • 11.4.1.1. U.S.
      • 11.4.1.2. Canada
    • 11.4.2. By Product Type
    • 11.4.3. By Route of Administration
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Country
    • 11.5.2. By Product Type
    • 11.5.3. By Route of Administration
  • 11.6. Market Trends
  • 11.7. Key Market Participants - Intensity Mapping
  • 11.8. Drivers and Restraints - Impact Analysis

12. Latin America Infant Clinical Nutrition Market Analysis 2019-2023 and Forecast 2024-2033

  • 12.1. Introduction
  • 12.2. Pricing Analysis
  • 12.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 12.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
    • 12.4.1. By Country
      • 12.4.1.1. Brazil
      • 12.4.1.2. Mexico
      • 12.4.1.3. Argentina
      • 12.4.1.4. Rest of Latin America
    • 12.4.2. By Product Type
    • 12.4.3. By Route of Administration
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Country
    • 12.5.2. By Product Type
    • 12.5.3. By Route of Administration
  • 12.6. Market Trends
  • 12.7. Key Market Participants - Intensity Mapping
  • 12.8. Drivers and Restraints - Impact Analysis

13. Europe Infant Clinical Nutrition Market Analysis 2019-2023 and Forecast 2024-2033

  • 13.1. Introduction
  • 13.2. Pricing Analysis
  • 13.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 13.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
    • 13.4.1. By Country
      • 13.4.1.1. Germany
      • 13.4.1.2. Italy
      • 13.4.1.3. France
      • 13.4.1.4. U.K.
      • 13.4.1.5. Spain
      • 13.4.1.6. BENELUX
      • 13.4.1.7. Russia
      • 13.4.1.8. Poland
      • 13.4.1.9. Rest of Europe
    • 13.4.2. By Product Type
    • 13.4.3. By Route of Administration
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Country
    • 13.5.2. By Product Type
    • 13.5.3. By Route of Administration
  • 13.6. Market Trends
  • 13.7. Key Market Participants - Intensity Mapping
  • 13.8. Drivers and Restraints - Impact Analysis

14. South Asia and Pacific Infant Clinical Nutrition Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Pricing Analysis
  • 14.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 14.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
    • 14.4.1. By Country
      • 14.4.1.1. India
      • 14.4.1.2. ASEAN
      • 14.4.1.3. Oceania (Australia & New Zealand)
      • 14.4.1.4. Rest of South Asia & Pacific
    • 14.4.2. By Product Type
    • 14.4.3. By Route of Administration
  • 14.5. Market Attractiveness Analysis
    • 14.5.1. By Country
    • 14.5.2. By Product Type
    • 14.5.3. By Route of Administration
  • 14.6. Market Trends
  • 14.7. Key Market Participants - Intensity Mapping
  • 14.8. Drivers and Restraints - Impact Analysis

15. East Asia Infant Clinical Nutrition Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Pricing Analysis
  • 15.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 15.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
    • 15.4.1. By Country
      • 15.4.1.1. China
      • 15.4.1.2. Japan
      • 15.4.1.3. South Korea
    • 15.4.2. By Product Type
    • 15.4.3. By Route of Administration
  • 15.5. Market Attractiveness Analysis
    • 15.5.1. By Country
    • 15.5.2. By Product Type
    • 15.5.3. By Route of Administration
  • 15.6. Market Trends
  • 15.7. Key Market Participants - Intensity Mapping
  • 15.8. Drivers and Restraints - Impact Analysis

16. Middle East and Africa Infant Clinical Nutrition Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Pricing Analysis
  • 16.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 16.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
    • 16.4.1. By Country
      • 16.4.1.1. GCC Countries
      • 16.4.1.2. Turkey
      • 16.4.1.3. Northern Africa
      • 16.4.1.4. South Africa
      • 16.4.1.5. Rest of Middle East and Africa
    • 16.4.2. By Product Type
    • 16.4.3. By Route of Administration
  • 16.5. Market Attractiveness Analysis
    • 16.5.1. By Country
    • 16.5.2. By Product Type
    • 16.5.3. By Route of Administration
  • 16.6. Market Trends
  • 16.7. Key Market Participants - Intensity Mapping
  • 16.8. Drivers and Restraints - Impact Analysis

17. Country Wise Infant Clinical Nutrition Market Analysis, 2024

  • 17.1. Introduction
    • 17.1.1. Market Value Proportion Analysis, By Key Countries
    • 17.1.2. Global Vs. Country Growth Comparison
  • 17.2. U.S. Infant Clinical Nutrition Market Analysis
    • 17.2.1. By Product Type
    • 17.2.2. By Route of Administration
  • 17.3. Canada Infant Clinical Nutrition Market Analysis
    • 17.3.1. By Product Type
    • 17.3.2. By Route of Administration
  • 17.4. Mexico Infant Clinical Nutrition Market Analysis
    • 17.4.1. By Product Type
    • 17.4.2. By Route of Administration
  • 17.5. Brazil Infant Clinical Nutrition Market Analysis
    • 17.5.1. By Product Type
    • 17.5.2. By Route of Administration
  • 17.6. Argentina Infant Clinical Nutrition Market Analysis
    • 17.6.1. By Product Type
    • 17.6.2. By Route of Administration
  • 17.7. Germany Infant Clinical Nutrition Market Analysis
    • 17.7.1. By Product Type
    • 17.7.2. By Route of Administration
  • 17.8. Italy Infant Clinical Nutrition Market Analysis
    • 17.8.1. By Product Type
    • 17.8.2. By Route of Administration
  • 17.9. France Infant Clinical Nutrition Market Analysis
    • 17.9.1. By Product Type
    • 17.9.2. By Route of Administration
  • 17.10. U.K. Infant Clinical Nutrition Market Analysis
    • 17.10.1. By Product Type
    • 17.10.2. By Route of Administration
  • 17.11. Spain Infant Clinical Nutrition Market Analysis
    • 17.11.1. By Product Type
    • 17.11.2. By Route of Administration
  • 17.12. Poland Infant Clinical Nutrition Market Analysis
    • 17.12.1. By Product Type
    • 17.12.2. By Route of Administration
  • 17.13. Russia Infant Clinical Nutrition Market Analysis
    • 17.13.1. By Product Type
    • 17.13.2. By Route of Administration
  • 17.14. China Infant Clinical Nutrition Market Analysis
    • 17.14.1. By Product Type
    • 17.14.2. By Route of Administration
  • 17.15. Japan Infant Clinical Nutrition Market Analysis
    • 17.15.1. By Product Type
    • 17.15.2. By Route of Administration
  • 17.16. S. Korea Infant Clinical Nutrition Market Analysis
    • 17.16.1. By Product Type
    • 17.16.2. By Route of Administration
  • 17.17. India Infant Clinical Nutrition Market Analysis
    • 17.17.1. By Product Type
    • 17.17.2. By Route of Administration
  • 17.18. Oceania (Australia and New Zealand) Infant Clinical Nutrition Market Analysis
    • 17.18.1. By Product Type
    • 17.18.2. By Route of Administration
  • 17.19. Turkey Infant Clinical Nutrition Market Analysis
    • 17.19.1. By Product Type
    • 17.19.2. By Route of Administration
  • 17.20. South Africa Infant Clinical Nutrition Market Analysis
    • 17.20.1. By Product Type
    • 17.20.2. By Route of Administration

18. Market Structure Analysis

  • 18.1. Market Analysis by Tier of Companies (Infant Clinical Nutrition)
  • 18.2. Market Share Analysis of Top Players
  • 18.3. Market Presence Analysis

19. Competition Analysis

  • 19.1. Competition Dashboard
  • 19.2. Competition Benchmarking
  • 19.3. Competition Deep Dive
    • 19.3.1. Abbott Laboratories
      • 19.3.1.1. Overview
      • 19.3.1.2. Product Portfolio
      • 19.3.1.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.3.1.4. Sales Footprint
      • 19.3.1.5. Strategy Overview
    • 19.3.2. Baxter International
      • 19.3.2.1. Overview
      • 19.3.2.2. Product Portfolio
      • 19.3.2.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.3.2.4. Sales Footprint
      • 19.3.2.5. Strategy Overview
    • 19.3.3. Nestle S.A.
      • 19.3.3.1. Overview
      • 19.3.3.2. Product Portfolio
      • 19.3.3.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.3.3.4. Sales Footprint
      • 19.3.3.5. Strategy Overview
    • 19.3.4. Danone
      • 19.3.4.1. Overview
      • 19.3.4.2. Product Portfolio
      • 19.3.4.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.3.4.4. Sales Footprint
      • 19.3.4.5. Strategy Overview
    • 19.3.5. Meiji Holdings Co., Ltd.
      • 19.3.5.1. Overview
      • 19.3.5.2. Product Portfolio
      • 19.3.5.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.3.5.4. Sales Footprint
      • 19.3.5.5. Strategy Overview
    • 19.3.6. Fresenius SE & Co. KGaA
      • 19.3.6.1. Overview
      • 19.3.6.2. Product Portfolio
      • 19.3.6.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.3.6.4. Sales Footprint
      • 19.3.6.5. Strategy Overview
    • 19.3.7. Reckitt Benckiser Group Plc
      • 19.3.7.1. Overview
      • 19.3.7.2. Product Portfolio
      • 19.3.7.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.3.7.4. Sales Footprint
      • 19.3.7.5. Strategy Overview
    • 19.3.8. Perrigo Co. Plc
      • 19.3.8.1. Overview
      • 19.3.8.2. Product Portfolio
      • 19.3.8.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.3.8.4. Sales Footprint
      • 19.3.8.5. Strategy Overview
    • 19.3.9. Ingredion Inc.
      • 19.3.9.1. Overview
      • 19.3.9.2. Product Portfolio
      • 19.3.9.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.3.9.4. Sales Footprint
      • 19.3.9.5. Strategy Overview
    • 19.3.10. Solace Nutrition
      • 19.3.10.1. Overview
      • 19.3.10.2. Product Portfolio
      • 19.3.10.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.3.10.4. Sales Footprint
      • 19.3.10.5. Strategy Overview
    • 19.3.11. Others ( on Additional Request)
      • 19.3.11.1. Overview
      • 19.3.11.2. Product Portfolio
      • 19.3.11.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.3.11.4. Sales Footprint
      • 19.3.11.5. Strategy Overview

20. Assumptions and Acronyms Used

21. Research Methodology